Search

everythinglearnresearchcommunity

for

Search:↓

There are now better methods for hair regrowth.

Post-steroid panniculitis is now rare because doctors taper steroids more carefully.

The IBHRS is now operational.

Advancements in technology now allow better evaluation and treatment for women with common hair loss problem, androgenic alopecia.

Botulinum and tetanus neurotoxins are better understood now, with updated information on their effects and treatment.

Forensic hair analysis for drugs is now more reliable and accurate.

Oral and maxillofacial surgeons are now well-equipped to offer comprehensive facial cosmetic care after additional training.

Lasers and light treatments are now the most common ways to remove hair.

Low-level laser therapy, now called photobiomodulation, is recognized for its broad medical applications and scientific backing.

More people are seeing dermatologists for hair and scalp problems now than in the past.

The Journal of Cutaneous and Aesthetic Surgery is now included in PubMed.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Doctors used to view PCOS too narrowly, but now understand that insulin resistance is a key factor in the condition.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Hair is culturally and economically valuable, and its weight is now used to measure the effectiveness of hair growth treatments.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Dr. Shoji Okuda was a pioneer in hair transplant surgery, but his work was initially overlooked and is now recognized alongside Dr. Norman Orentreich.

Researchers concluded that "spigo nardo" is the Himalayan plant Nardostachys jatamansi, used historically in medicine and cosmetics, now critically endangered.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

New small molecule drugs could help treat hair loss.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Young people are losing hair due to stress, poor diet, pollution, and lack of sleep, but it can be treated with supplements and scalp treatments.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

The conclusion is that Darier-White disease was accurately described by White but he missed the key feature of dyskeratotic cells which Darier identified.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

Hair loss can signal serious health issues, not just cosmetic concerns.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.